A Metabonomics Profiling Study on Phlegm Syndrome and Blood-Stasis Syndrome in Coronary Heart Disease Patients Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry

Table 2

Demographic and clinical characteristics of subjects.

Characteristics	Blood stasis syndrome; 𝑛=20	Phlegm syndrome; 𝑛=20	Healthy; 𝑛=16
Age (years)	61.05±11.77	62.08±10.15	60.27±12.04
Male	13 (65%)	17 (85%)	10 (62.5%)
BMI (kg/m^2)	23.11±1.45	27.72±0.86	23.60±0.87
Hypertension	6 (30%)	10 (50%)	6 (37.5%)
TG (mmol/L)	1.63±0.90	1.54±1.02	1.23±0.77
TC (mmol/L)	4.15±0.98	4.11±0.93	3.25±0.72
LDL (mmol/L)	2.21±0.93	2.08±0.93	2.02±0.44
HDL (mmol/L)	1.19±0.24	1.14±0.48	1.27±0.28
Apo (a1) (g/L)	1.29±0.21	1.17±0.21	1.33±0.14
Apo (b) (g/L)	1.04±0.33	0.77±0.19	0.62±0.30
LDH (U/L)	225.78±137.61	206.31±56.52	158.01±42.21
CK (U/L)	253.96±691.83	81.39±45.08	73.30±11.68
CK-MB (U/L)	19.27±21.95	19.11±10.02	24.45±14.80
Myoglobin (ug/L)	41.80±29.09	43.28±22.07	32.40±10.67
CTn1 (ug/L)	0.12±0.21	0.44±0.29	0.17±0.11